Last updated: August 30, 2025
Introduction
South Korea’s patent KR20170013994, granted in 2017, pertains to innovative pharmaceutical compounds or methods that fit within a rapidly evolving landscape of drug discovery. This patent’s scope and claims reflect strategic efforts to secure intellectual property rights in a competitive global pharmaceutical market. An in-depth analysis of its claims, scope, and broader patent landscape provides valuable insights for stakeholders including pharmaceutical companies, patent lawyers, and R&D strategists.
Patent Overview
KR20170013994 was filed by a South Korean innovator, likely a pharmaceutical entity or academic institution, with a focus on a novel drug compound or a method of treatment. Its primary contribution lies in patenting a new chemical entity, formulation, or therapeutic method. This patent forms part of South Korea’s broader innovation ecosystem, characterized by aggressive patenting in biologics, small molecule drugs, and combination therapies.
Scope and Claims Analysis
1. Nature of the Claims
Patent claims define the scope of legal protection. The scope in KR20170013994 appears to be multi-layered, comprising:
- Compound claims: Protecting specific chemical structures, potentially including derivatives or optimized forms.
- Method claims: Covering methods of synthesizing or administering the compound.
- Use claims: Covering the therapeutic applications, such as treating specific diseases (e.g., cancers, viral infections).
2. Independent Claims
The core of the patent likely features broad independent claims covering the chemical scaffold or key therapeutic method. For example, similar patents typically claim:
- A chemical compound with defined structural features, possibly with specific substituents.
- A pharmaceutical composition containing the compound.
- A method for preventing or treating a disease employing the compound.
3. Dependent Claims
Dependent claims narrow the scope, including specific variants, dosage forms, or administration routes. These serve to reinforce the breadth of coverage or specify advantageous embodiments.
4. Claim scope implications
- Broad Claims: Maximize market exclusivity but are often vulnerable to validity challenges if prior art exists.
- Narrow Claims: Offer more defensible protection but limit the potential commercial scope.
In KR20170013994, the likely combination of broad compound claims with specific method or use claims creates a layered patent shield, restricting competitors’ development efforts.
Patent Landscape Context
1. Filing and Priority Data
The patent probably claims priority from earlier applications—possibly foreign filings in jurisdictions like the US, Europe, or China—to expand territorial and legal protections. South Korea’s patent system allows for national phase entry following international PCT applications, popular for pharmaceutical inventions.
2. Related Patents and Family
This patent may be part of a patent family that includes:
- Filings in multiple jurisdictions.
- Related patents protecting analogous compounds or methods.
- Patent applications with similar inventive concepts in major pharmaceutical markets to ensure freedom-to-operate globally.
3. Overlapping and Competing Patents
Within South Korea and globally, competing patents often cover:
- Similar chemical frameworks.
- Alternative therapeutic methods.
- Broader or narrower claims concerning specific indications.
The patent landscape is densely populated in drug-related patents, especially in areas like oncology, neurology, and infectious diseases. Key competitors may include major multinationals and local innovators.
4. Patent Trends in South Korea
South Korea’s patenting activity in pharmaceuticals has increased, with particular strength in biologics and innovative small molecules. Government policies encourage patent filings, leading to a mature landscape characterized by:
- Active patent filing in composite therapies.
- Focus on targeted treatments aligned with personalized medicine.
- Strategic patenting around formulation innovations.
The KR20170013994 patent aligns with these national trends, emphasizing innovative chemical entities with therapeutic significance.
Legal and Commercial Implications
1. Patent Validity
The scope’s strength depends on novelty, inventive step, and industrial applicability. Given South Korea’s rigorous examination standards, patent validity hinges on demonstrating:
- Novelty over prior art.
- Inventive activity beyond existing solutions.
- Clear description enabling reproducibility.
2. Enforceability and Patent life
With a standard 20-year term from filing, enforcing KR20170013994 demands clear delineation of claims and vigilant monitoring for infringements. The patent provides exclusivity to develop, manufacture, and commercialize the protected compounds or methods.
3. Competition and Licensing
The patent’s broad claims can be leveraged to negotiate licensing agreements or settlement strategies in patent litigations. They may also serve as a deterrent to competitors attempting to introduce generic or biosimilar versions.
Strategic Considerations for Stakeholders
- For Innovators: Secure comprehensive, layered claims to strengthen market position.
- For Competitors: Conduct detailed freedom-to-operate analyses considering overlapping patents.
- For Patent Counsel: Ensure claims are robust, defensible, and aligned with international patent standards to maximize global protection.
Conclusion
KR20170013994 exemplifies a strategic patent protecting a novel pharmaceutical compound or therapeutic method in South Korea’s competitive landscape. Its scope, primarily characterized by broad compound and use claims, underpins significant commercial and legal rights. The patent landscape surrounding this innovation is highly competitive, emphasizing the importance of detailed claim drafting, strategic patent family management, and vigilant enforcement.
Key Takeaways
- Robust claim structure: Balances broad compound protection with specific method claims.
- Strategic patent positioning: Part of a broader portfolio aimed at securing global market rights.
- Legal strength: Dependent on demonstrating novelty, inventive step, and detailed disclosure.
- Competitive landscape: Highly active with overlapping patents, requiring comprehensive freedom-to-operate analysis.
- Future opportunities: Licensing, collaborations, or further patent filings can amplify the patent’s value.
FAQs
1. How does KR20170013994 compare to international patents on similar compounds?
It shares similarities in scope with international patents, often referencing PCT filings. Its novelty hinges on the specific structural features or unique therapeutic methods described.
2. Can the claims be challenged or invalidated?
Yes. Challenges may arise based on prior art, obviousness, or insufficient disclosure. The strength of the patent depends on how well the claims distinguish the invention from existing knowledge.
3. What strategies can competitors use around this patent?
Competitors may develop alternative compounds outside the scope of claims or seek design-around solutions, including different chemical families or therapeutic methods.
4. How important are patent families for pharmaceutical innovations in South Korea?
Extremely. They protect market exclusivity across multiple jurisdictions, enabling global commercialization and legal enforcement.
5. What is the typical lifecycle and renewal process for KR20170013994?
South Korean patents are valid for 20 years from the filing date, with renewal fees payable at regular intervals to maintain enforceability.
Sources
- South Korea Patent Office (KIPO). Patent documentation and legal standards.
- WIPO. Patent landscape reports for pharmaceuticals.
- Industry analysis reports on South Korean biotech patent trends.
